Clinical trial

Jan 2017_2 AARP
You may have heard in the news that yet another Alzheimer’s drug has failed to show efficacy in a large clinical trial.  Pharmaceutical company Eli Lilly announced last month that their drug Solanezumab had failed its second trial.
Search AARP States